Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

BRVE vs EWTX: stock comparison and AI forecast

Braveheart Bio, Inc. (BRVE) and Edgewise Therapeutics, Inc. (EWTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

BRVE Braveheart Bio, Inc.

Price
$21.51 -26.9% · 6M
Market Cap
$1.76B
P/E Ratio
–
Size
small-cap
AI Forecast
NO CURRENT FORECAST
Full analysis →
Nasdaq · Pharmaceutical Preparations

EWTX Edgewise Therapeutics, Inc.

Market Cap
$4.09B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

BRVE · EWTX

Key facts

  • EWTX is 2.3 times larger than BRVE by market capitalization ($4.09B against $1.76B).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricBRVEEWTX
Market Cap$1.76B$4.09B
P/B Ratio–9.13x
EPS–$-1.82
Book Value/Share–$4.13
FCF/Share–$-1.46

Profitability & Margins

MetricBRVEEWTX
ROE–-44.0%
ROA–-41.1%
ROIC–-48.6%

Financial Health

MetricBRVEEWTX
Current Ratio13.63x16.24x
D/E Ratio–0.07x
Financial Leverage–1.07x
Working Capital$114M$442M

Cash Flow

MetricBRVEEWTX
Operating Cash Flow–-$158M
Free Cash Flow–-$159M
Capital Spending–-$550K

Income Statement

MetricBRVEEWTX
Operating Income–-$219M
Net Income–-$197M
R&D Expense–$171M

Dividend & Shareholder Information

MetricBRVEEWTX
Shares Outstanding82M109M
FAQ

BRVE vs EWTX: stock comparison and AI forecast

Which is bigger, BRVE or EWTX?

EWTX is 2.3 times larger than BRVE by market capitalization ($4.09B against $1.76B).

Which one does Intratio's AI model rank higher, BRVE or EWTX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.